These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15066302)

  • 21. Dose distributions in bifurcated coronary vessels treated with catheter-based photon and beta emitters in intravascular brachytherapy.
    Yue N; Roberts KB; Pfau SE; Nath R
    Med Phys; 2003 Jul; 30(7):1628-36. PubMed ID: 12906180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
    Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
    Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
    Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
    Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques.
    Li XA; Wang R; Yu C; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1043-9. PubMed ID: 10705028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular brachytherapy to prevent restenosis: dosimetric considerations.
    Campos L; Stabin M
    Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):429-39. PubMed ID: 12146694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis.
    Bagga R; Kini A; Lee P; Agarwal A; Duffy M; Kim M; Sharma S
    J Invasive Cardiol; 2005 Jun; 17(6):302-6. PubMed ID: 16003004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
    Richter J; Baier K; Flentje M
    Strahlenther Onkol; 2008 Apr; 184(4):187-92. PubMed ID: 18398582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inaccuracy in manual multisegmental irradiation in coronary arteries.
    Coen VL; Marijnissen JP; Ligthart JM; de Pan C; Drenth J; den Boer A; van der Giessen WJ; Serruys PW; Levendag PC
    Radiother Oncol; 2002 Apr; 63(1):89-95. PubMed ID: 12065108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and safety of beta irradiation in human coronary arteries.
    Urban P; Verin V; Popowski Y; Rutishauser W
    Semin Interv Cardiol; 1997 Jun; 2(2):125-31. PubMed ID: 9546993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (144)Ce as a potential candidate for interstitial and intravascular brachytherapy.
    Zilio VO; Joneja OP; Popowski Y; Bochud FO; Chawla R
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):585-94. PubMed ID: 15890604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vessel geometry and catheter position on dose delivery in intracoronary brachytherapy.
    Wahle A; Lopez JJ; Pennington EC; Meeks SL; Braddy KC; Fox JM; Brennan TM; Buatti JM; Rossen JD; Sonka M
    IEEE Trans Biomed Eng; 2003 Nov; 50(11):1286-95. PubMed ID: 14619999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric measurements in isolated human coronary arteries: comparison of commercially available iridium(192) with strontium/yttrium(90) emitters.
    Hanefeld C; Amirie S; Borchardt D; Grewe P; Müller KM; Kissler M; Mügge A
    Circulation; 2002 May; 105(21):2493-6. PubMed ID: 12034655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America.
    Muñoz JS; Feres F; Abizaid AC; Mattos LA; Staico R; Centemero M; Tanajura LF; Pinto I; Sousa AG; Sousa JE
    Arq Bras Cardiol; 2004 Jul; 83(1):63-8; 57-62. PubMed ID: 15322668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta dosimetry with microMOSFETs for endovascular brachytherapy.
    Drud E; Todorovic M; Schönborn T; Schmidt R
    Phys Med Biol; 2006 Dec; 51(23):5977-86. PubMed ID: 17110764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose rate endovascular brachytherapy in aorto-iliac lesion for the prevention of restenosis.
    Yamazaki H; Tomoda K; Shiomi H; Maeda M; Kawata S; Okada A; Murakami T; Nakamura H; Tanaka E; Inoue T; Inoue T
    Radiat Med; 2002; 20(1):25-32. PubMed ID: 12002600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length.
    Syeda B; Siostrzonek P; Schmid R; Wexberg P; Kirisits C; Denk S; Beran G; Khorsand A; Lang I; Pokrajac B; Potter R; Glogar D
    J Am Coll Cardiol; 2002 Oct; 40(7):1225-31. PubMed ID: 12383569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.
    Pokrajac B; Pötter R; Wolfram RM; Budinsky AC; Kirisits C; Lileg B; Mendel H; Sabeti S; Schmid R; Minar E
    Radiother Oncol; 2005 Jan; 74(1):3-9. PubMed ID: 15683661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.